(Q36395731)

13 August 2017

1 reference

title

Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? (English)

1 reference

13 August 2017

2

1 reference

13 August 2017

3

Patrick D McGorry

1 reference

13 August 2017

Philippe Conus

1

1 reference

13 August 2017

publication date

1 March 2006

1 reference

Australian and New Zealand Journal of Psychiatry

13 August 2017

published in

1 reference

13 August 2017

volume

40

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

199-207

1 reference

First-episode mania: a neglected priority for early intervention

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Pharmacotherapy of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

International clinical practice guidelines for early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Reduced amygdalar gray matter volume in familial pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Novel antipsychotics in bipolar and schizoaffective mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

The initial prodrome to bipolar affective disorder: prospective case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Scale matters: the need for a Bipolar Depression Rating Scale (BDRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01775.X

10.1111/J.1440-1614.2006.01775.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference